Acrivon Therapeutics Price Chart
Acrivon Therapeutics Volume Chart
Acrivon Therapeutics Market Segments
Premarket
+0.03(+1.94%)
| Open | $1.52 |
|---|---|
| Close | $1.55 |
| Low | $1.52 |
| Low Change | 0.00 (0.00%) |
| High | $1.55 |
| High Change | +0.03 (+1.96%) |
| Range | $0.03 |
| Volume | 2.025K |
| Dollar Volume | $3.14K |
After Hours Yesterday
-0.05(-3.23%)
| Open | $1.55 |
|---|---|
| Close | $1.50 |
| Low | $1.48 |
| Low Change | -0.07 (-4.52%) |
| High | $1.55 |
| High Change | +0.00 (+0.00%) |
| Range | $0.07 |
| Volume | 24.182K |
| Dollar Volume | $36.27K |
Regular Trading Hours Yesterday
+0.08(+5.41%)
| Open | $1.48 |
|---|---|
| Close | $1.56 |
| Low | $1.44 |
| Low Change | -0.04 (-2.70%) |
| High | $1.59 |
| High Change | +0.11 (+7.43%) |
| Range | $0.15 |
| Volume | 666.753K |
| Dollar Volume | $1.04M |
Premarket Yesterday
-0.00(-0.27%)
| Open | $1.49 |
|---|---|
| Close | $1.49 |
| Low | $1.49 |
| Low Change | -0.00 (-0.27%) |
| High | $1.50 |
| High Change | +0.01 (+0.40%) |
| Range | $0.01 |
| Volume | 10.452K |
| Dollar Volume | $15.57K |
Acrivon Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.53 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.46 |
| 20 Day Moving Average (SMA20) | $1.55 |
| 50 Day Moving Average (SMA50) | $1.61 |
| 100 Day Moving Average (SMA100) | $1.94 |
| 200 Day Moving Average (SMA200) | $1.75 |
Acrivon Therapeutics Statistics
| Average Volume (30 Days) | 818.87K |
|---|---|
| P/E Ratio (Current) | -.76 |
| EPS (Current) | -$2.01 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$65.33M |
| Cash Ratio | 2.65 |
| Current Ratio | 7.69 |
| Quick Ratio | 7.69 |
| Debt to Equity | 0.00 |
| Enterprise Value | $17.78M |
| EV to EBITDA | -0.21 |
| EV to Sales | — |
| Price to Book | 0.53 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.60% |
| Return on Equity | -0.69% |
Acrivon Therapeutics Stock Splits
There have been no stock splits for Acrivon Therapeutics (ACRV).
Acrivon Therapeutics Dividends
There have been no dividends for Acrivon Therapeutics (ACRV).